ARNAUD SINAN KARABOGA,VIOLETA ISABEL PEREZ-NUENO,MICHEL SOUCHET,DIDIER DECAUDIN
申请号：
US15301462
公开号：
US20170119784A1
申请日:
2015.04.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a new class of cephalosporin derivatives of formula (I), notably having CXCR4 receptor antagonist effect, useful as a therapeutic agent for treating cancer, in particular for treating breast cancer, lung cancer and uveal melanoma. The invention further relates to a pharmaceutical composition comprising a compound of formula (I) and an additional antitumor drug for treating cancer.
